Petra Wilgenbus

3.1k citations

22 papers · 2.5k indexed · 1 hit paper · h-index 17

Co-authors: Gerhard Christofori Anne‐Karina T. Perl Ulf Dahl Henrik Semb Sven Horke Ines Witte Ulrich Förstermann Maximilian Krüger
Topics: Paraoxonase enzyme and polymorphisms (10 papers)Cancer-related gene regulation (4 papers)Virus-based gene therapy research (3 papers)
Cited by: Clinical Biochemistry Oncology Cancer Research
Journals: Nature Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: Germany United States Austria

In The Last Decade

Petra Wilgenbus

22 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A causal role for E-cadherin in the transition from adenoma to carcinoma

1998 1.2k citations Anne‐Karina T. Perl, Petra Wilgenbus et al. Nature profile →

Peers

Countries citing papers authored by Petra Wilgenbus

Since Specialization

Citations

This map shows the geographic impact of Petra Wilgenbus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Wilgenbus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Wilgenbus more than expected).

Fields of papers citing papers by Petra Wilgenbus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Wilgenbus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Wilgenbus. The network helps show where Petra Wilgenbus may publish in the future.

Co-authorship network of co-authors of Petra Wilgenbus

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Wilgenbus. A scholar is included among the top collaborators of Petra Wilgenbus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Wilgenbus. Petra Wilgenbus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Myeloid cell–synthesized coagulation factor X dampens antitumor immunity 2019 ·Science Immunology ·Claudine Graf,Petra Wilgenbus,(unknown),(unknown),Fédérico Marini,Sabine Reyda,Maki Kitano,Stephan Macher-Göppinger,Hartmut Weiler,Wolfram Ruf	94
2	Paraoxonase-2 regulates coagulation activation through endothelial tissue factor 2018 ·Blood ·(unknown),Petra Wilgenbus,John F. Teiber,Kerstin Jurk,Kathrin Schwierczek,(unknown),Ning Xia,Huige Li,(unknown),Wolfram Ruf,Sven Horke	48
3	The anti-apoptotic PON2 protein is Wnt/β-catenin-regulated and correlates with radiotherapy resistance in OSCC patients 2016 ·Oncotarget ·Maximilian Krüger,(unknown),Petra Wilgenbus,Johanna Helmstädter,(unknown),(unknown),Stefan Tenzer,Maximilian Moergel,Ines Witte,Sven Horke	31
4	PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death 2012 ·Cell Death and Differentiation ·(unknown),Asokan Devarajan,Ines Witte,Petra Wilgenbus,(unknown),Ulrich Förstermann,(unknown),Víctor Grijalva,Diana M. Shih,Robin Farias‐Eisner,John F. Teiber,Srinivasa T. Reddy,Sven Horke	71
5	Paraoxonases-2 and -3 Are Important Defense Enzymes againstPseudomonas aeruginosaVirulence Factors due to Their Anti-Oxidative and Anti-Inflammatory Properties 2012 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),Petra Wilgenbus,Ulrich Förstermann,John F. Teiber,Sven Horke	27
6	Beyond reduction of atherosclerosis: PON2 provides apoptosis resistance and stabilizes tumor cells 2011 ·Cell Death and Disease ·Ines Witte,Sebastian Altenhöfer,Petra Wilgenbus,(unknown),Albrecht M. Clement,Andrea Pautz,Huige Li,Ulrich Förstermann,Sven Horke	77
7	One Enzyme, Two Functions 2010 ·Journal of Biological Chemistry ·Sebastian Altenhöfer,Ines Witte,John F. Teiber,Petra Wilgenbus,Andrea Pautz,Huige Li,Andreas Daiber,(unknown),Albrecht M. Clement,Ulrich Förstermann,Sven Horke	137
8	Paraoxonase 2 is down-regulated by the Pseudomonas aeruginosa quorumsensing signal N-(3-oxododecanoyl)-L-homoserine lactone and attenuates oxidative stress induced by pyocyanin 2009 ·Biochemical Journal ·Sven Horke,Ines Witte,Sebastian Altenhöfer,Petra Wilgenbus,Marion Goldeck,Ulrich Förstermann,Junhui Xiao,Gerald L. Kramer,Donovan C. Haines,Puneet K. Chowdhary,Robert W. Haley,John F. Teiber	51
9	Protective effect of paraoxonase-2 against endoplasmic reticulum stress-induced apoptosis is lost upon disturbance of calcium homoeostasis 2008 ·Biochemical Journal ·Sven Horke,Ines Witte,Petra Wilgenbus,Sebastian Altenhöfer,Maximilian Krüger,Huige Li,Ulrich Förstermann	52
10	Paraoxonase-2 Reduces Oxidative Stress in Vascular Cells and Decreases Endoplasmic Reticulum Stress–Induced Caspase Activation 2007 ·Circulation ·Sven Horke,Ines Witte,Petra Wilgenbus,Maximilian Krüger,Dennis Strand,Ulrich Förstermann	208
11	Fibroblast growth factors are required for efficient tumor angiogenesis. 2000 ·PubMed ·Amelia Compagni,Petra Wilgenbus,(unknown),Matthew Cotten,Gerhard Christofori	192
12	Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic β tumor cells 1999 ·Nature Medicine ·Anne‐Karina T. Perl,Ulf Dahl,Petra Wilgenbus,Harold Cremer,Henrik Semb,Gerhard Christofori	108
13	A causal role for E-cadherin in the transition from adenoma to carcinomabreakdown → 1998 ·Nature ·Anne‐Karina T. Perl,Petra Wilgenbus,Ulf Dahl,Henrik Semb,Gerhard Christofori	1170
14	Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours 1998 ·British Journal of Cancer ·Zdeněk Sedláček,Roman Kodet,(unknown),E Seemanová,P Vodvářka,Petra Wilgenbus,J. Mareš,Albert J. Poustka,P Goetz	35
15	Chromosomal distribution of the hamster intracisternal A-particle (IAP) retrotransposons 1996 ·Chromosoma ·(unknown),Hilde Heller,Petra Wilgenbus,Sian T. Tjia,Walter Doerfler	11
16	On the insertion of foreign DNA into mammalian genomes: Mechanism and consequences 1995 ·Gene ·Walter Doerfler,Gertraud Orend,Rainer Schubbert,Katja Fechteler,Hilde Heller,Petra Wilgenbus,Jörg Schröer	11
17	Chromosomal insertion of foreign (adenovirus type 12, plasmid, or bacteriophage lambda) DNA is associated with enhanced methylation of cellular DNA segments. 1995 ·Proceedings of the National Academy of Sciences ·Hilde Heller,Christina Kämmer,Petra Wilgenbus,Walter Doerfler	97
18	The Mechanism of Adenovirus DNA Integration: Studies in a Cell-Free System 1995 ·Current topics in microbiology and immunology ·Katja Fechteler,Jörg Tatzelt,(unknown),Petra Wilgenbus,Walter Doerfler	10
19	A radiation hybrid map of human chromosome 18 1994 ·Cytogenetic and Genome Research ·Uta Francke,(unknown),(unknown),Eva-María Geigl,Joseph C. Giacalone,(unknown),Joseph M. Luna,Aree Moon,Susan K. Welch,Petra Wilgenbus	10
20	Mutation screening of complete fibrillin-1 coding sequence: report of five new mutations, including two in 8-cysteine domains 1993 ·Human Molecular Genetics ·Katherine Tynan,(unknown),Margaret M. Pearson,Petra Wilgenbus,(unknown),(unknown),Mary Anne Berg,D. Craig Miller,Uta Francke	73

About Petra Wilgenbus

Petra Wilgenbus is a scholar working on Clinical Biochemistry, Pharmacology and Nutrition and Dietetics, having authored 22 papers that have together received 2.5k indexed citations. Recurring topics across this work include Paraoxonase enzyme and polymorphisms (10 papers), Cancer-related gene regulation (4 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Clinical Biochemistry (483 citations), Oncology (653 citations) and Cancer Research (345 citations). Petra Wilgenbus has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Gerhard Christofori, Anne‐Karina T. Perl, Ulf Dahl, Henrik Semb, Sven Horke, Ines Witte, Ulrich Förstermann, Maximilian Krüger, Matthew Cotten and Amelia Compagni. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact